Literature DB >> 33216222

SQSTM1 gene as a potential genetic modifier of CADASIL phenotype.

Maria Rosário Almeida1, Ana Rita Silva2, Inês Elias2, Carolina Fernandes3, Rita Machado3, Orlando Galego4, Gustavo Cordeiro Santo2,3.   

Abstract

Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL) is the most common inherited cerebral small vessel disease and is caused by mutations in the NOTCH3 gene. Interestingly, CADASIL patients present a large phenotypic variability even harboring the same pathogenic variant. We describe two CADASIL siblings with a particularly aggressive clinical phenotype characterized by early-onset stroke, gait disturbances and/or dementia, severe emotional dysregulation, and dysexecutive syndrome together with a severe white matter burden on MRI. The genetic analysis revealed the co-occurrence of NOTCH3 (p.Gly420Cys) and SQSTM1 (p.Ser275Phefs*17) pathogenic variants which might worsen the aggressiveness of disease progression in both siblings. Interestingly, to the best of our knowledge, mutations in SQSTM1 gene have never been described in CADASIL patients before. Curiously, both Notch3 and p62 encoded proteins have a key role in the autophagy-lysosomal pathway which is impaired in CADASIL patients. Thus, the contribution of SQSTM1 gene to the clinical heterogeneity of CADASIL patients, in particular for those who develop cognitive impairment or dementia at an early age, is certainly overlooked. Therefore, we advocate expanding the genetic analysis to other genes associated with the phenotype spectrum of CADASIL patients using NGS-customized gene panel.

Entities:  

Keywords:  CADASIL; Dementia; Emotional dysregulation; NOTCH3; SQSTM1; White matter hyperintensities

Mesh:

Substances:

Year:  2020        PMID: 33216222     DOI: 10.1007/s00415-020-10308-5

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  60 in total

1.  Emotional disturbance in CADASIL: its impact on quality of life and caregiver burden.

Authors:  Sang-Mi Noh; Sun J Chung; Kwang-Kuk Kim; Dong-Wha Kang; Young-Min Lim; Sun U Kwon; Jong S Kim
Journal:  Cerebrovasc Dis       Date:  2014-02-05       Impact factor: 2.762

2.  Notch3 mutations in CADASIL, a hereditary adult-onset condition causing stroke and dementia.

Authors:  A Joutel; C Corpechot; A Ducros; K Vahedi; H Chabriat; P Mouton; S Alamowitch; V Domenga; M Cécillion; E Marechal; J Maciazek; C Vayssiere; C Cruaud; E A Cabanis; M M Ruchoux; J Weissenbach; J F Bach; M G Bousser; E Tournier-Lasserve
Journal:  Nature       Date:  1996-10-24       Impact factor: 49.962

3.  The ectodomain of the Notch3 receptor accumulates within the cerebrovasculature of CADASIL patients.

Authors:  A Joutel; F Andreux; S Gaulis; V Domenga; M Cecillon; N Battail; N Piga; F Chapon; C Godfrain; E Tournier-Lasserve
Journal:  J Clin Invest       Date:  2000-03       Impact factor: 14.808

Review 4.  CADASIL: hereditary disease of arteries causing brain infarcts and dementia.

Authors:  H Kalimo; M Viitanen; K Amberla; V Juvonen; R Marttila; M Pöyhönen; J O Rinne; M Savontaus; S Tuisku; B Winblad
Journal:  Neuropathol Appl Neurobiol       Date:  1999-08       Impact factor: 8.090

5.  Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy maps to chromosome 19q12.

Authors:  E Tournier-Lasserve; A Joutel; J Melki; J Weissenbach; G M Lathrop; H Chabriat; J L Mas; E A Cabanis; M Baudrimont; J Maciazek
Journal:  Nat Genet       Date:  1993-03       Impact factor: 38.330

6.  Cerebrovascular dysfunction and microcirculation rarefaction precede white matter lesions in a mouse genetic model of cerebral ischemic small vessel disease.

Authors:  Anne Joutel; Marie Monet-Leprêtre; Claudia Gosele; Céline Baron-Menguy; Annette Hammes; Sabine Schmidt; Barbara Lemaire-Carrette; Valérie Domenga; Andreas Schedl; Pierre Lacombe; Norbert Hubner
Journal:  J Clin Invest       Date:  2010-01-11       Impact factor: 14.808

7.  Long-term prognosis and causes of death in CADASIL: a retrospective study in 411 patients.

Authors:  Christian Opherk; Nils Peters; Jürgen Herzog; Rainer Luedtke; Martin Dichgans
Journal:  Brain       Date:  2004-09-13       Impact factor: 13.501

8.  The phenotypic spectrum of CADASIL: clinical findings in 102 cases.

Authors:  M Dichgans; M Mayer; I Uttner; R Brüning; J Müller-Höcker; G Rungger; M Ebke; T Klockgether; T Gasser
Journal:  Ann Neurol       Date:  1998-11       Impact factor: 10.422

9.  Clinical spectrum of CADASIL: a study of 7 families. Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy.

Authors:  H Chabriat; K Vahedi; M T Iba-Zizen; A Joutel; A Nibbio; T G Nagy; M O Krebs; J Julien; B Dubois; X Ducrocq
Journal:  Lancet       Date:  1995-10-07       Impact factor: 79.321

Review 10.  Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarcts and Leukoencephalopathy (CADASIL) as a model of small vessel disease: update on clinical, diagnostic, and management aspects.

Authors:  Ilaria Di Donato; Silvia Bianchi; Nicola De Stefano; Martin Dichgans; Maria Teresa Dotti; Marco Duering; Eric Jouvent; Amos D Korczyn; Saskia A J Lesnik-Oberstein; Alessandro Malandrini; Hugh S Markus; Leonardo Pantoni; Silvana Penco; Alessandra Rufa; Osman Sinanović; Dragan Stojanov; Antonio Federico
Journal:  BMC Med       Date:  2017-02-24       Impact factor: 8.775

View more
  1 in total

1.  NOTCH3 mutations in a cohort of Portuguese patients within CADASIL spectrum phenotype.

Authors:  Maria Rosário Almeida; Inês Elias; Carolina Fernandes; Rita Machado; Orlando Galego; Gustavo Santo
Journal:  Neurogenetics       Date:  2021-12-01       Impact factor: 2.660

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.